More than one million Americans have the serious gastrointestinal inflammation that comes with Crohn’s disease or ulcerative colitis. Taken together these are called inflammatory bowel disease or IBD. Up until fairly recently many people with these conditions required daily handfuls of drugs, fairly extensive surgery, and lifestyle changes to keep them close to the bathroom wherever they went. It was a constant worry that GI problems would severely limit enjoying life. Fortunately, new medicines are available – with more in late stage research – to limit or shutdown inflammation and reduce the need for surgery. In other cases, surgery can now be less extensive. Hear about progress in IBD from our highly respected gastroenterology experts.